An update on neurotoxin products and administration methods.
Since onabotulinumtoxinA for nonsurgical aesthetic enhancement of glabellar lines was initially reported, the popularity of botulinum neurotoxin (BoNT) products among both clinicians and consumers has rapidly grown, and we have seen several additional BoNT formulations enter the market. As the demand for minimally invasive cosmetic procedures continues to increase, we will see the introduction of additional formulations of BoNT products as well as new delivery devices and administration techniques. In this article, we provide a brief update on current and upcoming BoNT products and also review the literature on novel administration methods based on recently published studies.
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Julien
J
Lanoue
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Joanna
J
Dong
University of Central Florida, Orlando, USA.
Timothy
T
Do
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Gary
G
Goldenberg
D019274:Botulinum Toxins, Type A / Q000494:pharmacology*; D003357:Cosmetic Techniques / Q000639:trends*; D004333:Drug Administration Routes; D006801:Humans; D009465:Neuromuscular Agents / Q000494:pharmacology; D013518:Surgery, Plastic / Q000379:methods*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A